Dr. Ritchie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2093 Philadelphia Pike #2696
Claymont, DE 19703Fax+1 218-228-0904- Is this information wrong?
Education & Training
- University of LouisvilleCertificate, Biostatistics, 2021 - 2023
- University of MarylandResidency, Dermatology, 2010 - 2013
- David Grant Medical CenterInternship, Transitional Year, 2007 - 2008
- UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2007
Certifications & Licensure
- FL State Medical License 2022 - Present
- TN State Medical License 2024 - 2026
- WA State Medical License 2023 - 2026
- ND State Medical License 2022 - 2026
- TX State Medical License 2013 - 2025
- SD State Medical License Active through 2025
- MN State Medical License 2020 - 2025
- American Board of Dermatology Dermatology
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsShaving Waivers in the United States Air Force and Their Impact on Promotions of Black/African-American MembersSimon Ritchie, Jisuk Park, Jonathan Banta, Casey Bowen, Sean McCarthy, Emily P Wong, Romain Garnier, Thomas M. Beachkofsky> ;Military Medicine. 2021 Jul 6
- 8 citationsPredictive value of basal cell carcinoma biopsies with negative margins: A retrospective cohort studyHal Bret Willardson, Jamie Lombardo, Matt Raines, Tina Nguyen, Jisuk Park, Scott R. Dalton, Simon Ritchie> ;Journal of the American Academy of Dermatology. 2018 Jul 1
- 14 citationsA phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasisSimon Ritchie, Danielle Neal, Harold Shlevin, Adam Allgood, Peter G. Traber> ;Journal of the American Academy of Dermatology. 2017 Oct 1
- Join now to see all
Press Mentions
- GR-MD-02 Demonstrates Clinically Significant Effect in Patients with Severe and Refractory Atopic Dermatitis (Eczema)March 14th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: